Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
Clinical trial NCT02895100 · TERMINATED
Trial details
- NCT number
- NCT02895100
- Sponsor
- Protagonist Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-03-26
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.